374 related articles for article (PubMed ID: 28407379)
1. Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.
Francart ME; Lambert J; Vanwynsberghe AM; Thompson EW; Bourcy M; Polette M; Gilles C
Dev Dyn; 2018 Mar; 247(3):432-450. PubMed ID: 28407379
[TBL] [Abstract][Full Text] [Related]
2. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis.
Genna A; Vanwynsberghe AM; Villard AV; Pottier C; Ancel J; Polette M; Gilles C
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575608
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal plasticity in circulating tumor cells.
Alix-Panabières C; Mader S; Pantel K
J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis.
Burr R; Gilles C; Thompson EW; Maheswaran S
Adv Exp Med Biol; 2020; 1220():11-34. PubMed ID: 32304077
[TBL] [Abstract][Full Text] [Related]
6. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
[TBL] [Abstract][Full Text] [Related]
7. Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells.
Bourcy M; Suarez-Carmona M; Lambert J; Francart ME; Schroeder H; Delierneux C; Skrypek N; Thompson EW; Jérusalem G; Berx G; Thiry M; Blacher S; Hollier BG; Noël A; Oury C; Polette M; Gilles C
Cancer Res; 2016 Jul; 76(14):4270-82. PubMed ID: 27221703
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
10. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
11. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
13. A conduit to metastasis: circulating tumor cell biology.
Micalizzi DS; Maheswaran S; Haber DA
Genes Dev; 2017 Sep; 31(18):1827-1840. PubMed ID: 29051388
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients.
Tashireva LA; Savelieva OE; Grigoryeva ES; Nikitin YV; Denisov EV; Vtorushin SV; Zavyalova MV; Cherdyntseva NV; Perelmuter VM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801519
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kölbl AC; Jeschke U; Andergassen U
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
[TBL] [Abstract][Full Text] [Related]
19. Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.
Correnti M; Raggi C
Oncotarget; 2017 Jan; 8(4):7094-7115. PubMed ID: 27738343
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
Książkiewicz M; Markiewicz A; Zaczek AJ
Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]